Lushang Freda Pharmaceutical Co (SHSE:600223) Cyclically Adjusted Book per Share: ¥ (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600223 Lushang Freda Pharmaceutical Co Ltd SHSE:600223
67 GF Score
Price ¥5.71
GF Value ¥7.03
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lushang Freda Pharmaceutical Co Cyclically Adjusted Book per Share?

Lushang Freda Pharmaceutical Co SHSE:600223 +3.63% 67 Cyclically Adjusted Book per Share is ¥ as of Jun. 2026. GuruFocus rates SHSE:600223 with a GF Score™ of 67/100 and a GF Value™ of ¥7.03 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lushang Freda Pharmaceutical Co's adjusted book value per share for the three months ended in Jun. 2026 was ¥4.892. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥ for the trailing ten years ended in Jun. 2026.

During the past 12 months, Lushang Freda Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 6.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lushang Freda Pharmaceutical Co was 13.80% per year. The lowest was -7.50% per year. And the median was 6.05% per year.

As of today (2026-09-21), Lushang Freda Pharmaceutical Co's current stock price is ¥5.71. Lushang Freda Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 was ¥. Lushang Freda Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lushang Freda Pharmaceutical Co was 7.30. The lowest was 1.41. And the median was 2.99.


Lushang Freda Pharmaceutical Co  (SHSE:600223) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lushang Freda Pharmaceutical Co was 7.30. The lowest was 1.41. And the median was 2.99.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lushang Freda Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Lushang Freda Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Lushang Freda Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lushang Freda Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Lushang Freda Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Lushang Freda Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Lushang Freda Pharmaceutical Co Cyclically Adjusted Book per Share Competitor Comparison

For the Real Estate - Development subindustry, Lushang Freda Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lushang Freda Pharmaceutical Co Cyclically Adjusted PB Ratio vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Lushang Freda Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lushang Freda Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600223
67GF Score
Lushang Freda Pharmaceutical Co Ltd SHSE:600223
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lushang Freda Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lushang Freda Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book= Book Value per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.892/116.0564*116.0564
=4.892

Current CPI (Jun. 2026) = 116.0564.

Lushang Freda Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201609 2.524 102.400 2.861
201612 2.547 102.600 2.881
201703 2.570 103.200 2.890
201706 2.588 103.100 2.913
201709 2.636 104.100 2.939
201712 2.618 104.500 2.908
201803 2.646 105.300 2.916
201806 2.669 104.900 2.953
201809 2.769 106.600 3.015
201812 2.891 106.500 3.150
201903 2.972 107.700 3.203
201906 3.032 107.700 3.267
201909 3.642 109.800 3.850
201912 4.691 111.200 4.896
202003 4.909 112.300 5.073
202006 5.007 110.400 5.264
202009 5.370 111.700 5.579
202012 5.568 111.500 5.796
202103 5.575 112.662 5.743
202106 5.578 111.769 5.792
202109 5.234 112.215 5.413
202112 5.549 113.108 5.694
202203 5.598 114.335 5.682
202206 5.594 114.558 5.667
202209 5.643 115.339 5.678
202212 5.476 115.116 5.521
202303 4.478 115.116 4.515
202306 4.536 114.558 4.595
202309 4.598 115.339 4.627
202312 4.604 114.781 4.655
202403 4.675 115.227 4.709
202406 4.657 114.781 4.709
202409 4.680 115.785 4.691
202412 4.710 114.893 4.758
202503 4.772 115.116 4.811
202506 4.790 114.907 4.838
202509 4.809 115.471 4.833
202512 4.867 115.832 4.876
202603 4.904 116.303 4.894
202606 4.892 116.056 4.892

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥ mean?
Lushang Freda Pharmaceutical Co (SHSE:600223) has a Cyclically Adjusted Book per Share of ¥ as of Jun. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lushang Freda Pharmaceutical Co and its competitors.
Is Lushang Freda Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Lushang Freda Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥. Overall, Lushang Freda Pharmaceutical Co has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lushang Freda Pharmaceutical Co's Cyclically Adjusted Book per Share compare to competitors?
Lushang Freda Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥ can be compared against companies in the Real Estate industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Real Estate company?
A good Cyclically Adjusted Book per Share depends on the Real Estate industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Lushang Freda Pharmaceutical Co and its competitors. Lushang Freda Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lushang Freda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co (SHSE:600223) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.03, compared to a current price of ¥5.71 — trading 18.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is ¥. Lushang Freda Pharmaceutical Co's overall GF Score™ is 67/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Lushang Freda Pharmaceutical Co (SHSE:600223), the current Cyclically Adjusted Book per Share is ¥ as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lushang Freda Pharmaceutical Co (SHSE:600223) Overvalued in 2026?

Based on GuruFocus' analysis, Lushang Freda Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥5.71 is trading 18.8% below its estimated GF Value™ of ¥7.03. GuruFocus considers Lushang Freda Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600223:

  • Cyclically Adjusted Book per Share: ¥
  • GF Value™: ¥7.03 vs. price of ¥5.71 (18.8% below fair value)
  • GF Score™: 67/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600223 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lushang Freda Pharmaceutical Co Business Description

Address No. 9777 Jingshi Road, Building 5, Lixia District, Jinan City, CHN
Lushang Freda Pharmaceutical Co Ltd formerly Lushang Health Industry Development Co Ltd is a real estate developer in China. The company is engaged in the development of office buildings, infrastructure, apartments, and hotels.
67GF Score

Get the complete analysis for SHSE:600223

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥5.71
Price
¥7.03
GF Value